One under-the-radar biotech company could be your next big bet in the IPO market, says Renaissance Capital co-founder
January 24, 2020 at 10:47 AM EST
Under-the-radar biotechnology company PPD could be worth watching as it gears up for a 2020 initial public offering, says Kathleen Smith, co-founder and chairman at Renaissance Capital.